Close
Login to MyACC
ACC Members


Not a Member?

The Association of Corporate Counsel (ACC) is the world's largest organization serving the professional and business interests of attorneys who practice in the legal departments of corporations, associations, nonprofits and other private-sector organizations around the globe.

Join ACC

13100 Results

Resource Listings

Sample Forms, Policies, and Contracts

Employment, Confidential Information and Invention Assignment Agreement

This is a sample employment, confidential information and invention assignment agreement, under which a new employee assigns the right, title, and interest in and to inventions and other intellectual property items that the employee may conceive, develop or reduce to practice during the employment period. 

Sample Forms, Policies, and Contracts

Employee Intellectual Property Assignment and Confidential Agreement

This is a sample employee intellectual property assignment and confidentiality agreement, under which an employee, among other covenants, assigns to the company intellectual property such as designs, inventions, improvements, technical information, know-how, technology and suggestions relating in any way to the products or services of the company, which the employee conceives, develops, or contributes to or acquire during the employment period.

Sample Forms, Policies, and Contracts

Operating Agreement Regarding Transportation

Sample agreement between a common carrier and a contractor, for the supply by the contractor of motor vehicle equipment and personnel (drivers) that the carrier will utilize in the delivery of transportation services (agreement governed by the laws of the State of Alabama).

Articles

Growing Scrutiny of Private Equity in Health Care

By Lori A. Rubin, Michelle A. Freeman, Samantha Robbins Jamali

The presence of private equity (PE) investment has exploded in recent years in all areas of the health care sector. PE in health care is a good thing when done right: It can pave the way for much needed innovation, efficiency, and nontraditional care delivery models. However, government regulators, media journalists, some health care practitioners, and private parties are watching PE investment with growing suspicion that profit-driven goals may conflict with the quality of care for patients.

Articles

Considerations When Conducting Decentralized Clinical Trials

By Kyle Y. Faget

Although use of telehealth in clinical trials is not new, the modality was not popularized until social distancing efforts brought about by COVID-19 forced the issue. Companies interested in providing clinical trial services via telehealth have to deal with whether the carrying out the clinical aspects of a clinical trial is part of the practice of medicine.

Articles

Building Biotech with Brains: Strategies for Maximizing Value of AI-Driven Biotechnology Inventions

By Aashish R. Karkhanis, Jeffrey Simon

The rapid rise of artificial intelligence (AI) and machine learning (ML) in biotechnology products and services is becoming a driver of the personalized medicine and health care sectors. While this integration can require special consideration during development of a patent portfolio, stakeholders across engineering, legal, and executive teams in both established companies and start-ups can leverage it to create valuable intellectual property (IP) assets in the marketplace.

Articles

2023 Telemedicine & Digital Health Trends

By Thomas B. Ferrante, Rachel B. Goodman, Jennifer J. Hennessy, Jacqueline N. Acosta, Sunny J. Levine, Aaron T. Maguregui, Sarah J. Iacomini, Kristen A. Murphy

Medicare telehealth post-Public Health Emergency (PHE): With the COVID-19 PHE concluding on May 11, 2023, many of the telehealth flexibilities the Centers for Medicare & Medicaid Services (CMS) implemented during the PHE will sunset at varying times.

Articles

The BioPharma Patent Cliff: 2023 and Beyond

By Jason N. Mock

Between now and 2030, the biopharma sector is expected to be rocked by a number of high-profile patent cliffs that are likely to reshape the market in potentially unpredictable ways. A “patent cliff” refers to the end of IP protection for a drug that has enjoyed market exclusivity since its launch.

Articles

New Data Privacy Laws Now Playing at a Theatre New You. Are you Ready?

By Tara Cho, Ted Claypoole

2023 is shaping up to be a landmark year for data privacy, as comprehensive consumer privacy laws take effect in four states and a fifth state expands its already robust privacy compliance requirements. Womble Bond Dickinson assembled a panel of privacy, technology and data security attorneys to discuss these upcoming changes and the regulatory compliance steps companies need to take. This article is taken from that conversation. 

Articles

Today's Remote Workplace

By John Pueschel, Mark Henriques

This resource from Womble Bond Dickinson discusses how remote and hybrid work bring new legal and compliance challenges for in-house counsel.

ACC